DocDollars

Horizon Therapeutics Plc

CA · United States · Reporting entity ID 100000131389

Total reported 2019–2025
$131.9M
#77 of 2,960 reporting companies — 0.2% of all reported industry payments
$55.8M in general payments across 311,735 records, plus $76.1M in research funding across 1,194 records.

How it breaks down

General payments $55,833,806
Research funding $76,052,960

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Horizon Therapeutics Plc reported $131.9M to US doctors and teaching hospitals from 2019 to 2025, ranking #77 of 2,960 reporting companies. 58% of that was research funding and 42% general payments such as consulting, speaking, food and travel. 311,735 general payment records and 1,194 research records were filed.

Common questions about Horizon Therapeutics Plc

How much has Horizon Therapeutics Plc paid US doctors?

Horizon Therapeutics Plc reported $131,886,766 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $55,833,806 in general payments, $76,052,960 in research funding.

How does Horizon Therapeutics Plc rank among drug and device companies?

It ranks #77 of 2,960 reporting entities by total reported value, about 0.2% of all industry payments in the dataset.

Does a payment from Horizon Therapeutics Plc mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.